Related Experiment Video
Updated: Jun 21, 2025

09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
Acquired Risk Factors that Influence Risk for Dementia and Possibly Alzheimer Disease
Eric Novak1,2, Matthew Tochtrop3,4, David Schlagel3,5
1Instructor, Department of Psychiatry, University of South Dakota Sanford School of Medicine.
Summary
Recognizing acquired risk factors for dementia, including Alzheimer's disease (AD), is crucial for prevention. This article reviews factors that can be modified to potentially reduce dementia risk.
Area of Science:
- Neurology
- Gerontology
- Public Health
Background:
- Alzheimer's disease (AD) and other dementias are significant global health challenges.
- Current treatments for AD, such as cholinesterase inhibitors and aducanumab, primarily manage symptoms after diagnosis.
- There is a growing need to identify and mitigate factors that contribute to dementia development.
Purpose of the Study:
- To summarize acquired risk factors associated with dementia development.
- To highlight the importance of addressing modifiable risk factors for dementia prevention.
- To provide a foundation for understanding dementia etiology beyond genetic predispositions.
Main Methods:
- Literature review of studies identifying acquired risk factors for dementia.
- Synthesis of evidence on factors influencing dementia risk.
- Categorization of risk factors based on their acquired nature.
Main Results:
- Identified key acquired risk factors including cardiovascular issues, lifestyle choices, and environmental exposures.
- Emphasized that many dementia risk factors are potentially modifiable.
- Highlighted the interplay between various acquired factors in increasing dementia risk.
Conclusions:
- Proactive identification and management of acquired risk factors are essential for dementia prevention strategies.
- Interventions targeting modifiable risk factors may significantly decrease the incidence of dementia, including Alzheimer's disease.
- A comprehensive approach considering both clinical treatment and preventative measures is vital for combating the dementia epidemic.
Related Concept Videos
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27
Alzheimer's Disease: Treatment
177
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
177
Aging
41
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
41
Human Genetics
556
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
556

